Literature DB >> 22502652

Antitumor effects of hyperthermic CO2 pneumoperitoneum on human gastric cancer cells.

Hou-Min Zhou1, Bo Feng, Hong-Chao Zhao, Min-Hua Zheng.   

Abstract

AIM: To elucidate the effects of hyperthermic CO2 pneumoperitoneum on human gastric AGS cells.
METHODS: Based on a newly devised in vitro study model, we evaluated the anti-cancer effects of HT-CO2 (42-44 degrees C for 2-4h) on human gastric cancer cells, and also the corresponding mechanisms.
RESULTS: HT-CO2 (42-44 degrees C for 2-4h) severely inhibited cell proliferation as assessed by Cell Counting Kit-8 assay, while inducing apoptosis in a temperature- and time-dependent manner demonstrated by annexin-V/PI flow cytometry and morphological analysis (Hoechst/PI fluorescence). In addition, it was found that HT-CO2 (42-44 degrees C for 2-4h) promoted the up-regulation of Bax by western blotting. Significantly, it could also suppress gastric cancer cell invasion and metastasis by in vitro invasion and motility assay.
CONCLUSION: In conclusion, HT-CO2 had an efficacious cytotoxic effect on gastric cancer cells through Bax-induced mitochondrial apoptotic signaling. Our studies indicate that it may serve as a potential therapy for peritoneal carcinomatosis of gastric cancer. Further investigations in vivo using animal models are now urgently needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22502652     DOI: 10.7314/apjcp.2012.13.1.117

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Effect of hyperthermic CO2-treated dendritic cell-derived exosomes on the human gastric cancer AGS cell line.

Authors:  Jinlin Wang; Zhiyong Wang; Yanxia Mo; Zhaohui Zeng; Pei Wei; Tao Li
Journal:  Oncol Lett       Date:  2015-04-27       Impact factor: 2.967

2.  Inhibition of peritoneal dissemination of colon cancer by hyperthermic CO2 insufflation: A novel approach to prevent intraperitoneal tumor spread.

Authors:  Yuanfei Peng; Hua Yang; Qing Ye; Houming Zhou; Minhua Zheng; Yinghong Shi
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.